Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00409201
Show Display Options
Download search resultsDownload the search results for:
NCT00409201 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: reboxetine adjuvant therapy

Indicates status has not been verified in more than two years